Apollo Life Sciences: Media Releases

NEWS ROOM


Professor Paul Zimmet AO Head of International Diabetes Institute, Melbourne
"The data that I have seen so far makes this one of the most forward looking and best prospects of an oral insulin"
Click here to see Paul Zimmet's view on Apollo's oral insulin


Bill Moss AM Non-Executive Director and Investor
"Apollo has a number of opportunities to grow into the future. Opportunities perhaps that are much greater than many other companies many times their size"
Click here to hear Bill Moss's view on investing in Apollo

Media Releases

		20 August 2007
		Apollo enters supply agreement with Millipore
		18 June 2007
		A new insulin tablet offers hope for an end to daily insulin injections (The Bulletin)
		16 June 2007
		Apollo's human proteins boost stem cell research
		30 April 2007
		Apollo develops needle-free topical vaccine
		April 2007
		Apollo prepares for lift-off (Australian Life Scientist)
		4 April 2007
		Breakthrough tablet for arthritis sufferers
		Rheumatoid Arthritis: Fact Sheet
		27 Feb 2007
		Apollo $5 million capital raising (private placement and SPP)
		1 Feb 2007
		Successful oral insulin toxicity results
		30 Nov 2006
		HIV expert hails Apollo's contribution
		29 Nov 2006
		Apollo raises $10 million
		13 Nov 2006
		Stem cell hope for chemotherapy patients
		31 Oct 2006
		Apollo begins tests of arthritis drugs in tablet form
		17 Oct 2006
		No need for needles: psoriasis treatment outperforms competitors
		25 Sep 2006
		Diabetes authority applauds Australian "needle-free treatment" breakthrough
		3 Jul 2006
		Transdermal delivery breakthrough: needle-free biologics
		22 Jun 2006
		Apollo initiates efficacy studies on oral delivery of proteins